Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | FTH1 | P02794 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21473189 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL21473331 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL14776371 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL14849904 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL21473187 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL18553077 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL2852967 | 0.84 | CYP3A4 (0.36) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL24052372 | 0.78 | PDE4D (0.33) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL13935542 | 0.78 | CYP3A4 (0.34) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL10261799 | 0.78 | PDE4D (0.33) | CYP3A4FTH1CYP2C9CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140060324-A1 | METHOD OF PREPARING GAS SELECTIVE MEMBRANE USING EPOXY-FUNCTIONAL SILOXANES | DOW CORNING CORPORATION (US) | 2014-03-06 | — | — | US | claimed |
| US-7771794-B2 | Active energy ray-curable, organopolysiloxane resin composition, light-transmitting component, and method for manufacturing the light-transmitting component | DOW CORNING CORPORATION (US) | 2010-08-10 | — | — | US | claimed |
| EP-0476925-B1 | UV light-curable organopolysiloxane composition | SHINETSU CHEMICAL CO (JP) | 1996-12-11 | — | — | EP | claimed |
| US-5364888-A | Polyoxyalkylene glycol provides improved miscibility with onium salt initiator | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-11-15 | — | — | US | claimed |
| CN-1023230-C | Oxidation resistant compositions for use with rare earth magnets | GOODRICH CO B F (US) | 1993-12-22 | — | — | CN | claimed |
| EP-0476925-A2 | UV light-curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-03-25 | — | — | EP | claimed |
| EP-0179355-B1 | NOVEL TERPENE DERIVED FUNCTIONAL SILANES | PCR GROUP, INC. (US) | 1991-01-16 | — | — | EP | claimed |
| CN-1039832-A | The antioxidizing composition that is used for rare-earth magnet | GOODRICH CO B F (US) | 1990-02-21 | — | — | CN | claimed |
| EP-0179355-A2 | Novel terpene derived functional silanes | PCR GROUP, INC. (US) | 1986-04-30 | — | — | EP | claimed |
| WO-2024145273-A2 | N-MYRISTOYLTRANSFERASE INHIBITORS AND METHODS OF USE | SEATTLE CHILDREN'S HOSPITAL (D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE) (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4392430-A1 | MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS | Yale University (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20240181438-A1 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-06-06 | — | — | US | disclosed |
| US-20240165597-A1 | STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-05-23 | — | — | US | disclosed |
| WO-2024097160-A1 | TRANSITION METAL COMPLEXES FOR MRI APPLICATIONS AND METHODS OF USE | YALE UNIVERSITY (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-1023230-C | Oxidation resistant compositions for use with rare earth magnets | GOODRICH CO B F (US) | 1993-12-22 | — | — | CN | disclosed |
| US-5190988-A | Ultraviolet-curable organopolysiloxane composition containing a benzoinsulphonate initiator and metal catalyst | SHIN-ETSU CHEMICAL COMPANY, LIMITED (JP) | 1993-03-02 | — | — | US | disclosed |
| EP-0523527-A2 | Curable silicone-based release agent, separator having cured film formed from the same, and pressure-sensitive tape having cured film formed from the same | NITTO DENKO CORPORATION (JP) | 1993-01-20 | — | — | EP | disclosed |
| EP-0476925-A2 | UV light-curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-03-25 | — | — | EP | disclosed |
| EP-0179355-B1 | NOVEL TERPENE DERIVED FUNCTIONAL SILANES | PCR GROUP, INC. (US) | 1991-01-16 | — | — | EP | disclosed |
| CN-1039832-A | The antioxidizing composition that is used for rare-earth magnet | GOODRICH CO B F (US) | 1990-02-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240181438-A1 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | NDC1, NUDC, NSFL1C | CYP3A4 408/4885FTH1 1362/4885CYP2C9 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.